Becton, Dickinson and Co. | BDX - Operating Expenses


Becton, Dickinson and Co. reported $4.59B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Agilent USD 1.44B 27M Dec/2025
Align Technology USD 822.85M 11.8M Dec/2025
AngioDynamics USD 81.95M 1.68M Sep/2025
Avanos Medical USD 156.13M 2.7M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Boston Scientific USD 4.04B 18M Dec/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
Danaher USD 5.34B 45.74B Dec/2025
Dentsply International USD 423M 1.06B Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Globus Medical USD 645.11M 241.46M Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Masimo USD 328.6M 181.6M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Solventum Corp USD 1.89B 3.09B Dec/2025
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025